Background: In patients with diabetes related end-stage renal disease (ESRD) on hemodialysis, blood glucose management can be challenging due to the kinetics of glucose and insulin in addition to other factors. The glucose monitoring systems which measure glucose levels continuously may be useful to study the glucose profile of patients with diabetes undergoing hemodialysis. Our study is designed to use ambulatory glucose profile to study the glucose pattern – during, before, and after a session of hemodialysis. Materials and Methods: Ten patients with type 2 diabetes with ESRD undergoing hemodialysis were recruited. Forty-eight glucose readings were recorded in a 12-h period which included 4 h each prior, during, and after the dialysis ses...
Introduction: Chronic and post-prandial hyperglycemia are independent risk factors for diabetic comp...
Background/Aim: It is still controversial whether tighter glycemic control is associated with better...
Background Plasma glucose variability may confer a risk for development of chronic diabetic complica...
Objective: The objective of the study is to assess the glycemic pattern of patients undergoing haemo...
Background: Flash glucose monitoring (FGM) is a technology with considerable differences compared to...
Hypoglycemia has been documented during regular hemodialysis (HD) in both diabetic and nondiabetic e...
BACKGROUND/AIMS: Recent evidences suggest that hemodialysis (HD) induces glycemic variations in dia...
Background: Hemodialysis (HD) impacts glucose and insulin metabolism and increases hypoglycaemia rat...
International audienceBACKGROUND: The proportion of diabetic patients undergoing haemodialysis is ra...
OBJECTIVE — Optimizing glycemic control in diabetic patients undergoing maintenance hemodialysis req...
Purpose: Diabetes mellitus (DM) is the most common cause of end-stage renal disease and is an import...
Objective To compare the occurrence of hypoglycemia during hemodialysis in chronic kidney disease di...
Diabetes is the leading cause of end-stage renal disease (ESRD) and contributes to heightened morbid...
Continuous glucose monitoring (CGM) facilitates the assessment of short-term glucose variability and...
Patients with type 2 diabetes (T2D) and end-stage kidney disease (ESKD) on renal replacement therapy...
Introduction: Chronic and post-prandial hyperglycemia are independent risk factors for diabetic comp...
Background/Aim: It is still controversial whether tighter glycemic control is associated with better...
Background Plasma glucose variability may confer a risk for development of chronic diabetic complica...
Objective: The objective of the study is to assess the glycemic pattern of patients undergoing haemo...
Background: Flash glucose monitoring (FGM) is a technology with considerable differences compared to...
Hypoglycemia has been documented during regular hemodialysis (HD) in both diabetic and nondiabetic e...
BACKGROUND/AIMS: Recent evidences suggest that hemodialysis (HD) induces glycemic variations in dia...
Background: Hemodialysis (HD) impacts glucose and insulin metabolism and increases hypoglycaemia rat...
International audienceBACKGROUND: The proportion of diabetic patients undergoing haemodialysis is ra...
OBJECTIVE — Optimizing glycemic control in diabetic patients undergoing maintenance hemodialysis req...
Purpose: Diabetes mellitus (DM) is the most common cause of end-stage renal disease and is an import...
Objective To compare the occurrence of hypoglycemia during hemodialysis in chronic kidney disease di...
Diabetes is the leading cause of end-stage renal disease (ESRD) and contributes to heightened morbid...
Continuous glucose monitoring (CGM) facilitates the assessment of short-term glucose variability and...
Patients with type 2 diabetes (T2D) and end-stage kidney disease (ESKD) on renal replacement therapy...
Introduction: Chronic and post-prandial hyperglycemia are independent risk factors for diabetic comp...
Background/Aim: It is still controversial whether tighter glycemic control is associated with better...
Background Plasma glucose variability may confer a risk for development of chronic diabetic complica...